Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
19 angezeigte Treffer · Seite 1, keine Gesamtzahl für „lecanemab“
Suchtreffer
Begriffe & Kennungen
Lecanemab
Eintrag öffnenLeqembi · 4.3 · Treatment with lecanemab should not be initiated in patients receiving ongoing anticoagulant therapy (see sect
Eintrag öffnenLeqembi · 4.5 · Elimination of lecanemab is likely to occur through normal degradation pathways for immunoglobulins and the cl
Eintrag öffnenLeqembi · 4.5 · No drug interaction studies have been conducted with lecanemab.
Eintrag öffnenLeqembi · 4.5 · The risk of intracerebral haemorrhage with lecanemab treatment may be increased in patients receiving anticoag
Eintrag öffnenLeqembi · 4.8 · ARIA-H (with or without concurrent ARIA-E) was observed in 13% (98/757) of patients on lecanemab and 7% (52/76
Eintrag öffnenLeqembi · 4.8 · ARIA-H was observed in 13% (98/757) of patients on lecanemab compared with 7% (52/764) of patients on placebo.
Eintrag öffnenLeqembi · 4.8 · In Study 301, ARIA-E was observed in 9% (67/757) of patients on lecanemab compared with 1% (10/764) of patient
Eintrag öffnenLeqembi · 4.8 · In Study 301, symptomatic ARIA occurred in 2% (16/757) patients on lecanemab who are non- carriers and heteroz
Eintrag öffnenLeqembi · 4.8 · Including asymptomatic radiographic events, ARIA was observed in 17% (128/757) of patients on lecanemab compar
Eintrag öffnenLeqembi · 4.8 · Infusion-related reactions were observed in Study 301 in 26% (237/898) patients treated with lecanemab and 75%
Eintrag öffnenLeqembi · 4.8 · Isolated ARIA-H was observed in 8% (61/757) of patients on lecanemab and 6% (45/764) of patients on placebo, o
Eintrag öffnenLeqembi · 4.8 · Of the patients treated with lecanemab 31% (278/898) were non-carriers, 53% (479/898) were heterozygotes and 1
Eintrag öffnenLeqembi · 4.8 · Recurrence of ARIA in the Indicated Population ARIA-E was observed in 9% (67/757) of patients on lecanemab, of
Eintrag öffnenLeqembi · 4.8 · Seizures including status epilepticus have been reported with lecanemab treatment in the clinical trials.
Eintrag öffnenLeqembi · 4.8 · The following adverse reactions listed in Table 2 below have been reported in clinical trials with lecanemab.
Eintrag öffnenLeqembi · 4.8 · The maximum radiographic severity of ARIA-H microhaemorrhage in patients on lecanemab was mild in 8% (60/757),
Eintrag öffnenLeqembi · 4.8 · The safety of lecanemab has been evaluated in 2203 patients who received at least one dose of lecanemab.
Eintrag öffnenlecanemab
Eintrag öffnen